137 related articles for article (PubMed ID: 28595270)
1. SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells.
Vianello S; Pantic B; Fusto A; Bello L; Galletta E; Borgia D; Gavassini BF; Semplicini C; Sorarù G; Vitiello L; Pegoraro E
Hum Mol Genet; 2017 Sep; 26(17):3342-3351. PubMed ID: 28595270
[TBL] [Abstract][Full Text] [Related]
2. TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle.
Piva L; Gavassini BF; Bello L; Fanin M; Soraru G; Barp A; Ermani M; Angelini C; Hoffman EP; Pegoraro E
J Pathol; 2012 Oct; 228(2):251-9. PubMed ID: 22431140
[TBL] [Abstract][Full Text] [Related]
3. Eccentric muscle challenge shows osteopontin polymorphism modulation of muscle damage.
Barfield WL; Uaesoontrachoon K; Wu CS; Lin S; Chen Y; Wang PC; Kanaan Y; Bond V; Hoffman EP
Hum Mol Genet; 2014 Aug; 23(15):4043-50. PubMed ID: 24626632
[TBL] [Abstract][Full Text] [Related]
4. Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy.
Bello L; Piva L; Barp A; Taglia A; Picillo E; Vasco G; Pane M; Previtali SC; Torrente Y; Gazzerro E; Motta MC; Grieco GS; Napolitano S; Magri F; D'Amico A; Astrea G; Messina S; Sframeli M; Vita GL; Boffi P; Mongini T; Ferlini A; Gualandi F; Soraru' G; Ermani M; Vita G; Battini R; Bertini E; Comi GP; Berardinelli A; Minetti C; Bruno C; Mercuri E; Politano L; Angelini C; Hoffman EP; Pegoraro E
Neurology; 2012 Jul; 79(2):159-62. PubMed ID: 22744661
[TBL] [Abstract][Full Text] [Related]
5. SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy.
Pegoraro E; Hoffman EP; Piva L; Gavassini BF; Cagnin S; Ermani M; Bello L; Soraru G; Pacchioni B; Bonifati MD; Lanfranchi G; Angelini C; Kesari A; Lee I; Gordish-Dressman H; Devaney JM; McDonald CM;
Neurology; 2011 Jan; 76(3):219-26. PubMed ID: 21178099
[TBL] [Abstract][Full Text] [Related]
6.
Kosac A; Pesovic J; Radenkovic L; Brkusanin M; Radovanovic N; Djurisic M; Radivojevic D; Mladenovic J; Ostojic S; Kovacevic G; Kravljanac R; Savic Pavicevic D; Milic Rasic V
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011296
[TBL] [Abstract][Full Text] [Related]
7. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
[TBL] [Abstract][Full Text] [Related]
8. Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy.
Barp A; Bello L; Politano L; Melacini P; Calore C; Polo A; Vianello S; Sorarù G; Semplicini C; Pantic B; Taglia A; Picillo E; Magri F; Gorni K; Messina S; Vita GL; Vita G; Comi GP; Ermani M; Calvo V; Angelini C; Hoffman EP; Pegoraro E
PLoS One; 2015; 10(10):e0141240. PubMed ID: 26513582
[TBL] [Abstract][Full Text] [Related]
9. Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study.
Bello L; Kesari A; Gordish-Dressman H; Cnaan A; Morgenroth LP; Punetha J; Duong T; Henricson EK; Pegoraro E; McDonald CM; Hoffman EP;
Ann Neurol; 2015 Apr; 77(4):684-96. PubMed ID: 25641372
[TBL] [Abstract][Full Text] [Related]
10. Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants.
van den Bergen JC; Hiller M; Böhringer S; Vijfhuizen L; Ginjaar HB; Chaouch A; Bushby K; Straub V; Scoto M; Cirak S; Humbertclaude V; Claustres M; Scotton C; Passarelli C; Lochmüller H; Muntoni F; Tuffery-Giraud S; Ferlini A; Aartsma-Rus AM; Verschuuren JJ; 't Hoen PA; Spitali P
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1060-5. PubMed ID: 25476005
[TBL] [Abstract][Full Text] [Related]
11. Alterations in osteopontin modify muscle size in females in both humans and mice.
Hoffman EP; Gordish-Dressman H; McLane VD; Devaney JM; Thompson PD; Visich P; Gordon PM; Pescatello LS; Zoeller RF; Moyna NM; Angelopoulos TJ; Pegoraro E; Cox GA; Clarkson PM
Med Sci Sports Exerc; 2013 Jun; 45(6):1060-8. PubMed ID: 23274598
[TBL] [Abstract][Full Text] [Related]
12. Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy.
Bello L; Flanigan KM; Weiss RB; ; Spitali P; Aartsma-Rus A; Muntoni F; Zaharieva I; Ferlini A; Mercuri E; Tuffery-Giraud S; Claustres M; Straub V; Lochmüller H; Barp A; Vianello S; Pegoraro E; Punetha J; Gordish-Dressman H; Giri M; McDonald CM; Hoffman EP;
Am J Hum Genet; 2016 Nov; 99(5):1163-1171. PubMed ID: 27745838
[TBL] [Abstract][Full Text] [Related]
13. Modifier genes and their effect on Duchenne muscular dystrophy.
Vo AH; McNally EM
Curr Opin Neurol; 2015 Oct; 28(5):528-34. PubMed ID: 26263473
[TBL] [Abstract][Full Text] [Related]
14. Genetic modifiers of respiratory function in Duchenne muscular dystrophy.
Bello L; D'Angelo G; Villa M; Fusto A; Vianello S; Merlo B; Sabbatini D; Barp A; Gandossini S; Magri F; Comi GP; Pedemonte M; Tacchetti P; Lanzillotta V; Trucco F; D'Amico A; Bertini E; Astrea G; Politano L; Masson R; Baranello G; Albamonte E; De Mattia E; Rao F; Sansone VA; Previtali S; Messina S; Vita GL; Berardinelli A; Mongini T; Pini A; Pane M; Mercuri E; Vianello A; Bruno C; Hoffman EP; Morgenroth L; Gordish-Dressman H; McDonald CM; ; Pegoraro E
Ann Clin Transl Neurol; 2020 May; 7(5):786-798. PubMed ID: 32343055
[TBL] [Abstract][Full Text] [Related]
15. OPN-a induces muscle inflammation by increasing recruitment and activation of pro-inflammatory macrophages.
Many GM; Yokosaki Y; Uaesoontrachoon K; Nghiem PP; Bello L; Dadgar S; Yin Y; Damsker JM; Cohen HB; Kornegay JN; Bamman MM; Mosser DM; Nagaraju K; Hoffman EP
Exp Physiol; 2016 Oct; 101(10):1285-1300. PubMed ID: 27452303
[TBL] [Abstract][Full Text] [Related]
16. Genetic Modifiers of Duchenne Muscular Dystrophy in Chinese Patients.
Chen M; Wang L; Li Y; Chen Y; Zhang H; Zhu Y; He R; Li H; Lin J; Zhang Y; Zhang C
Front Neurol; 2020; 11():721. PubMed ID: 32849198
[No Abstract] [Full Text] [Related]
17. Serum Osteopontin as a Novel Biomarker for Muscle Regeneration in Duchenne Muscular Dystrophy.
Kuraoka M; Kimura E; Nagata T; Okada T; Aoki Y; Tachimori H; Yonemoto N; Imamura M; Takeda S
Am J Pathol; 2016 May; 186(5):1302-12. PubMed ID: 26963343
[TBL] [Abstract][Full Text] [Related]
18. Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne muscular dystrophy.
Galindo CL; Soslow JH; Brinkmeyer-Langford CL; Gupte M; Smith HM; Sengsayadeth S; Sawyer DB; Benson DW; Kornegay JN; Markham LW
Pediatr Res; 2016 Apr; 79(4):629-36. PubMed ID: 26672735
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin is linked with AKT, FoxO1, and myostatin in skeletal muscle cells.
Nghiem PP; Kornegay JN; Uaesoontrachoon K; Bello L; Yin Y; Kesari A; Mittal P; Schatzberg SJ; Many GM; Lee NH; Hoffman EP
Muscle Nerve; 2017 Dec; 56(6):1119-1127. PubMed ID: 28745831
[TBL] [Abstract][Full Text] [Related]
20. SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy: predicting the severity of Duchenne muscular dystrophy: implications for treatment.
Kyriakides T; Pegoraro E; Hoffman EP; Piva L; Cagnin S; Lanfranchi G; Griggs RC; Nelson SF
Neurology; 2011 Nov; 77(20):1858; author reply 1858-9. PubMed ID: 22084278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
